Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Equity Average (2016 - 2025)

Bio Key International's Equity Average history spans 15 years, with the latest figure at $6.4 million for Q3 2025.

  • For Q3 2025, Equity Average rose 1496.94% year-over-year to $6.4 million; the TTM value through Sep 2025 reached $6.4 million, up 1496.94%, while the annual FY2024 figure was $2.4 million, 24.03% down from the prior year.
  • Equity Average for Q3 2025 was $6.4 million at Bio Key International, down from $7.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $20.0 million in Q1 2021 and bottomed at -$461625.0 in Q3 2024.
  • The 5-year median for Equity Average is $6.4 million (2025), against an average of $8.1 million.
  • The largest annual shift saw Equity Average soared 6164.77% in 2021 before it tumbled 221.55% in 2024.
  • A 5-year view of Equity Average shows it stood at $16.6 million in 2021, then plummeted by 50.22% to $8.3 million in 2022, then plummeted by 96.5% to $289008.0 in 2023, then skyrocketed by 575.6% to $2.0 million in 2024, then soared by 230.27% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Equity Average are $6.4 million (Q3 2025), $7.2 million (Q2 2025), and $5.6 million (Q1 2025).